BI-4394
(BI4394) manufacturers
- MMP13-IN-3
-
- $89.00 / 1mg
-
2024-11-19
- CAS:1222173-37-6
- Min. Order:
- Purity: 99.05%
- Supply Ability: 10g
|
| | BI-4394
(BI4394) Basic information |
| Product Name: | BI-4394
(BI4394) | | Synonyms: | BI-4394
(BI4394);MMP13-IN-3;inhibit,osteoarthritis,Inhibitor,MMP13 IN 3,Matrix metalloproteinases,MMP-13-IN-3,MMP13IN3,MMP,MMP-13;BI-4394;1H-Indole-2-carboxylic acid, 5-[3-[[[(4-carboxyphenyl)methyl]amino]carbonyl]-1-methyl-1H-pyrazol-5-yl]-, 2-ethyl ester;MMP13-IN-3, 10 mM in DMSO | | CAS: | 1222173-37-6 | | MF: | C24H22N4O5 | | MW: | 446.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1222173-37-6.mol |  |
| | BI-4394
(BI4394) Chemical Properties |
| Boiling point | 764.4±60.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 100 mg/mL (223.98 mM; ultrasonic and warming and heat to 60°C) | | form | A solid | | pka | 4.16±0.10(Predicted) | | color | White to off-white |
| | BI-4394
(BI4394) Usage And Synthesis |
| Uses | MMP13-IN-3 is a potent and orally active matrix metalloproteinase-13 (MMP-13) inhibitor for the potential treatment of osteoarthritis and other related arthritic diseases. |
| | BI-4394
(BI4394) Preparation Products And Raw materials |
|